Research hotspots and frontiers in acral melanoma: A bibliometric analysis from 1999 to 2023

Background: Acral melanoma (AM), an aggressive subtype of melanoma with poor prognosis, has been increasingly studied. The present study aims to discuss the current status, hotspots and future directions of AM studies through visualized analysis with bibliometrics and knowledge graph. Method: Public...

Full description

Bibliographic Details
Main Authors: Yi Wang, Jie Pan, Mi Wang, Juan Su
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023109285
_version_ 1797336974926807040
author Yi Wang
Jie Pan
Mi Wang
Juan Su
author_facet Yi Wang
Jie Pan
Mi Wang
Juan Su
author_sort Yi Wang
collection DOAJ
description Background: Acral melanoma (AM), an aggressive subtype of melanoma with poor prognosis, has been increasingly studied. The present study aims to discuss the current status, hotspots and future directions of AM studies through visualized analysis with bibliometrics and knowledge graph. Method: Publications related to acral melanoma from January 1999 to May 2023 were searched and retrieved from the Web of Science. Data extraction and visualization of the top 10 publications by year of publication, journal, country and core author were performed using R Studio (Version 4.3.0) and Scimago Graphica (Version 1.0.34). Co-reference graphs regarding country/region, organization, author, and keywords, as well as reference collaborative network, co-occurrence network, and references were plotted using VOSviewer (Version 1.6.19) and CiteSpace (Version 6.2.R3). Results: A total of 1387 articles related to AM published in English from 1999 to 2023 were included in the present study. A total of 7499 authors were from 2092 organizations in 50 countries. The articles were published in 356 journals, involving 4131 keywords and 28,200 references. The 1387 articles related to AM had been cited a total of 10,014 times by the time of this study. The result showed that Journal of the American Academy of Dermatology had the largest number of citations and citation rate, with a total of 60 publications having been cited 2191 times. Having the top three productivity institutions in the world, the US is the most productive country in this field, with a total of 361 publications. The authors with the highest number of publications were Guo Jun (n = 43) and Si Lu (n = 38) from Peking University. The keyword burstiness test found that “ipilimumab”, “open label”, “efficacy” and “nivolumab” appeared most frequently in recent years. The co-cited reference timeline graph showed that the clustering of “advanced melanoma” and “melanocytic lesion” has been a hotspot since 2016. Conclusions: The number of AM-related studies has been increasing. The clinical characteristics and immunotherapy of AM are still key research directions, with the US playing a leading role in this field. This bibliometric analysis found up to 1387 publications, which not only comprehensively and quantitatively reflected the research trends and hotspots, but also provided a theoretical basis for future studies of AM. Researchers can benefit from choosing the right journals and finding potential collaborators or partner institutions.
first_indexed 2024-03-08T09:02:40Z
format Article
id doaj.art-924c85bb1eaa44eb90f2fd33b42fff4b
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-08T09:02:40Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-924c85bb1eaa44eb90f2fd33b42fff4b2024-02-01T06:33:09ZengElsevierHeliyon2405-84402024-01-01101e23720Research hotspots and frontiers in acral melanoma: A bibliometric analysis from 1999 to 2023Yi Wang0Jie Pan1Mi Wang2Juan Su3Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan, China; The Fifth People's Hospital of Hainan Province / Affiliated Dermatology Hospital of Hainan Medical University, Haikou City, Hainan, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Mental Health Center, Xiangya Hospital, Central South University, Changsha, China; Corresponding author. Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan, China.Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China; Corresponding author. Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan, China.Background: Acral melanoma (AM), an aggressive subtype of melanoma with poor prognosis, has been increasingly studied. The present study aims to discuss the current status, hotspots and future directions of AM studies through visualized analysis with bibliometrics and knowledge graph. Method: Publications related to acral melanoma from January 1999 to May 2023 were searched and retrieved from the Web of Science. Data extraction and visualization of the top 10 publications by year of publication, journal, country and core author were performed using R Studio (Version 4.3.0) and Scimago Graphica (Version 1.0.34). Co-reference graphs regarding country/region, organization, author, and keywords, as well as reference collaborative network, co-occurrence network, and references were plotted using VOSviewer (Version 1.6.19) and CiteSpace (Version 6.2.R3). Results: A total of 1387 articles related to AM published in English from 1999 to 2023 were included in the present study. A total of 7499 authors were from 2092 organizations in 50 countries. The articles were published in 356 journals, involving 4131 keywords and 28,200 references. The 1387 articles related to AM had been cited a total of 10,014 times by the time of this study. The result showed that Journal of the American Academy of Dermatology had the largest number of citations and citation rate, with a total of 60 publications having been cited 2191 times. Having the top three productivity institutions in the world, the US is the most productive country in this field, with a total of 361 publications. The authors with the highest number of publications were Guo Jun (n = 43) and Si Lu (n = 38) from Peking University. The keyword burstiness test found that “ipilimumab”, “open label”, “efficacy” and “nivolumab” appeared most frequently in recent years. The co-cited reference timeline graph showed that the clustering of “advanced melanoma” and “melanocytic lesion” has been a hotspot since 2016. Conclusions: The number of AM-related studies has been increasing. The clinical characteristics and immunotherapy of AM are still key research directions, with the US playing a leading role in this field. This bibliometric analysis found up to 1387 publications, which not only comprehensively and quantitatively reflected the research trends and hotspots, but also provided a theoretical basis for future studies of AM. Researchers can benefit from choosing the right journals and finding potential collaborators or partner institutions.http://www.sciencedirect.com/science/article/pii/S2405844023109285Bibliometric analysisAcral melanomaHotspotResearch trends
spellingShingle Yi Wang
Jie Pan
Mi Wang
Juan Su
Research hotspots and frontiers in acral melanoma: A bibliometric analysis from 1999 to 2023
Heliyon
Bibliometric analysis
Acral melanoma
Hotspot
Research trends
title Research hotspots and frontiers in acral melanoma: A bibliometric analysis from 1999 to 2023
title_full Research hotspots and frontiers in acral melanoma: A bibliometric analysis from 1999 to 2023
title_fullStr Research hotspots and frontiers in acral melanoma: A bibliometric analysis from 1999 to 2023
title_full_unstemmed Research hotspots and frontiers in acral melanoma: A bibliometric analysis from 1999 to 2023
title_short Research hotspots and frontiers in acral melanoma: A bibliometric analysis from 1999 to 2023
title_sort research hotspots and frontiers in acral melanoma a bibliometric analysis from 1999 to 2023
topic Bibliometric analysis
Acral melanoma
Hotspot
Research trends
url http://www.sciencedirect.com/science/article/pii/S2405844023109285
work_keys_str_mv AT yiwang researchhotspotsandfrontiersinacralmelanomaabibliometricanalysisfrom1999to2023
AT jiepan researchhotspotsandfrontiersinacralmelanomaabibliometricanalysisfrom1999to2023
AT miwang researchhotspotsandfrontiersinacralmelanomaabibliometricanalysisfrom1999to2023
AT juansu researchhotspotsandfrontiersinacralmelanomaabibliometricanalysisfrom1999to2023